Aytu Biopharma (AYTU) Free Cash Flow (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Free Cash Flow of -$4.2 million for Q1 2026, up 35.9% year-over-year from -$3.1 million in Q1 2025, and down 214.32% quarter-over-quarter from $3.7 million in Q4 2025.
Aytu Biopharma (AYTU) Free Cash Flow (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Free Cash Flow for 17 consecutive years, with -$4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 35.9% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at $1.6 million (up 127.09% YoY), while the FY2025 annual figure was -$2.2 million, down 26.09% from the prior year.
- Free Cash Flow declined to -$4.2 million in Q1 2026 per AYTU's latest filing, from $3.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $9.4 million in Q2 2023 and bottomed at -$9.1 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$1.6 million across 5 years, with a median of -$1.1 million in 2024.
- Annual changes were most pronounced in 2024 — Free Cash Flow surged 2247.41% — and 2025, when it tumbled 2468.5%.
- Aytu Biopharma's Free Cash Flow stood at -$2.5 million in 2022, then surged by 94.57% to -$135000.0 in 2023, then soared by 2247.41% to $2.9 million in 2024, then advanced by 26.18% to $3.7 million in 2025, then plunged by 214.32% to -$4.2 million in 2026.
- Business Quant data shows AYTU's Free Cash Flow at -$4.2 million in Q1 2026, $3.7 million in Q4 2025, and -$618000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | -4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.18 Mn |
| Mar 31, 2026 | -4.18 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | -618,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Jun 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | -6.52 Mn |
| Mar 31, 2025 | -6.52 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Jun 30, 2024 | -1.12 Mn |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -254,000.00 |
| Mar 31, 2024 | -254,000.00 |
| Dec 31, 2023 | -135,000.00 |
| Dec 31, 2023 | -135,000.00 |